Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 118 filers reported holding Y-MABS THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $4,684,000 | -35.5% | 94,615 | -50.0% | 0.02% | -42.3% |
Q3 2020 | $7,263,000 | -56.0% | 189,197 | -50.5% | 0.03% | -21.2% |
Q2 2020 | $16,504,000 | +30.5% | 382,050 | -21.2% | 0.03% | +3.1% |
Q1 2020 | $12,648,000 | -11.4% | 484,560 | +6.0% | 0.03% | +10.3% |
Q4 2019 | $14,282,000 | +76.2% | 457,022 | +46.9% | 0.03% | +81.2% |
Q3 2019 | $8,104,000 | +13.8% | 311,010 | -0.1% | 0.02% | +14.3% |
Q2 2019 | $7,120,000 | – | 311,284 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sofinnova Investments, Inc. | 2,104,278 | $55,890,000 | 4.98% |
SCOPIA CAPITAL MANAGEMENT LP | 1,587,566 | $42,166,000 | 0.81% |
DC Investments Management, LLC | 25,000 | $664,000 | 0.45% |
Monashee Investment Management LLC | 67,800 | $1,801,000 | 0.38% |
Avoro Capital Advisors LLC | 310,000 | $8,234,000 | 0.38% |
Cormorant Asset Management, LP | 200,000 | $5,312,000 | 0.34% |
PURA VIDA INVESTMENTS, LLC | 22,350 | $594,000 | 0.12% |
Artal Group S.A. | 150,000 | $3,984,000 | 0.10% |
OXFORD ASSET MANAGEMENT LLP | 59,122 | $1,556,000 | 0.03% |
Point72 Hong Kong Ltd | 3,252 | $86,000 | 0.03% |